Szczegóły publikacji

Opis bibliograficzny

Intracellular uptake of magnetic nanocapsules with ionic chitosan shells and magnetically triggered cargo release / Elżbieta GUMIENICZEK-CHŁOPEK, Joanna Odrobińska-Baliś, Adriana GILARSKA, Gabriela OPIŁA, Manuel Ricardo Ibarra, Czesław KAPUSTA, Szczepan Zapotoczny // Nanotechnology, Science and Applications [Dokument elektroniczny]. — Czasopismo elektroniczne ; ISSN 1177-8903. — 2025 — vol. 18, s. 263–275. — Wymagania systemowe: Adobe Reader. — Bibliogr. s. 274–275, Abstr. — Publikacja dostępna online od: 2025-06-07

Autorzy (7)

Słowa kluczowe

magnetic nanoparticlesiron oxide nanoparticlespolymer capsulesnanomedicinenanocarriersdrug delivery systems

Dane bibliometryczne

ID BaDAP160616
Data dodania do BaDAP2025-07-02
Tekst źródłowyURL
DOI10.2147/NSA.S515639
Rok publikacji2025
Typ publikacjiartykuł w czasopiśmie
Otwarty dostęptak
Creative Commons
Czasopismo/seriaNanotechnology, Science and Applications

Abstract

Introduction: Drug delivery systems typically need to be equipped with targeting moieties in order to be efficiently internalized by cells. Alternatively, magnetic nanoparticles (MNs) combined with active compounds may be driven by magnetic field to the site of action. Delivery of hydrophobic drugs using this approach is challenging as it would require coupling of MNs and hydrophobic environment within nanocarriers and triggering of the drug release. Methods: We propose an approach enabling a magnetically induced forced uptake of core-shell nanocapsules carrying hydrophobic actives together with hydrophobized MNs. Such capsules, formed in a facile emulsification process, are composed of amphiphilic cationic or anionic chitosan (shell) and oil-dispersible MNs (oil core). The capsules were characterized using DLS, cryo-TEM. They were loaded with a model fluorescent dye, Nile Red, and pulled into cells applying a static magnetic field. Then, they were treated with an alternating magnetic field to disrupt the capsules thanks to the action of MNs. Results: Cryo-TEM imaging confirmed the presence of MNs inside the capsules (d≈200 nm). Confocal microscopy imaging showed the efficient capsules’ intracellular uptake only after exposition to static magnetic field (some spontaneous uptake was observed for anionic capsules). Then, application of alternating magnetic fields induced rapture of the capsules inside the cells and release of the cargo. Discussion: This approach is very versatile as various lipophilic compounds could be encapsulated, then transported to desired tissues without active or passive targeting and kept there using static magnetic field, limiting undesired side effects of a therapy to the whole organism. The proposed capsules with MNs respond efficiently to magnetic field stimulation – they can be magnetically navigated into the cells and release their cargo after application of alternating magnetic field. This approach opens opportunities for controlled intracellular delivery of hydrophobic actives using easily applicable magnetic stimuli for both delivery and release.

Publikacje, które mogą Cię zainteresować

dokument patentowy
#152450Data dodania: 24.3.2024
Magnetic polymer nanocapsules suitable for use in therapy, especially anti-cancer therapy / Uniwersytet Jagielloński, Kraków; Akademia Górniczo-Hutnicza im. Stanisława Staszica w Krakowie ; wynalazca: ZAPOTOCZNY Szczepan, Odrobińska-Baliś Joanna, GUMIENICZEK-CHŁOPEK Elżbieta, KAPUSTA Czesław. — Int.Cl.: A61K 41/00(2020.01). — World Intellectual Property Organization. — Opis zgłoszeniowy wynalazku ; WO2024033546A1 ; Opubl. 2024-02-15. — Zgłosz. nr EP2023072350W z dn. 2023-08-11
dokument patentowy
#152448Data dodania: 24.3.2024
Magnetic polymer nanocapsules suitable for use in therapy, especially anti-cancer ones / Uniwersytet Jagielloński, Kraków; Akademia Górniczo-Hutnicza im. Stanisława Staszica w Krakowie ; wynalazca: ZAPOTOCZNY Szczepan, Odrobińska-Baliś Joanna, GUMIENICZEK-CHŁOPEK Elżbieta, KAPUSTA Czesław. — Int.Cl.: A61K 41/00(2020.01). — European Patent Office. — Opis zgłoszeniowy wynalazku ; EP4321175A1 ; Opubl. 2024-02-14. — Zgłosz. nr EP22461593A z dn. 2022-08-11